Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Non-Current Assets (2020 - 2025)

Biofrontera has reported Non-Current Assets over the past 6 years, most recently at $10.5 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $10.5 million for Q4 2025, up 648.11% from a year ago — trailing twelve months through Dec 2025 was $14.1 million (up 22.22% YoY), and the annual figure for FY2025 was $10.5 million, up 648.11%.
  • Non-Current Assets for Q4 2025 was $10.5 million at Biofrontera, up from $1.0 million in the prior quarter.
  • Over the last five years, Non-Current Assets for BFRIW hit a ceiling of $10.5 million in Q4 2025 and a floor of $1.0 million in Q3 2025.
  • Median Non-Current Assets over the past 5 years was $4.7 million (2023), compared with a mean of $4.7 million.
  • Peak annual rise in Non-Current Assets hit 648.11% in 2025, while the deepest fall reached 71.58% in 2025.
  • Biofrontera's Non-Current Assets stood at $6.8 million in 2021, then rose by 13.92% to $7.7 million in 2022, then tumbled by 37.28% to $4.9 million in 2023, then crashed by 71.16% to $1.4 million in 2024, then surged by 648.11% to $10.5 million in 2025.
  • The last three reported values for Non-Current Assets were $10.5 million (Q4 2025), $1.0 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.